Sep 2026· Molecular Imaging and Biology· 1 citation· 84 references
Medicine
TL;DR
This review critically evaluates the role of AI throughout the cancer theranostic workflow, with a focus on its potential to address the key clinical and technical challenges that continue to limit the routine implementation of personalized radiopharmaceutical therapy.
Abstract
Artificial intelligence (AI) is transforming cancer management and theranostics by improving the accuracy, efficiency, and personalization of diagnostic and therapeutic workflows. Routine and accurate clinical implementation of theranostics remains limited by complex dosimetry procedures, demanding imaging protocols, and challenges in quantitative image analysis. This review critically evaluates the role of AI throughout the cancer theranostic workflow, with a focus on its potential to address the key clinical and technical challenges that continue to limit the routine implementation of personalized radiopharmaceutical therapy. It examines the current maturity of AI applications, their readiness for clinical translation, and the future prospects. Recent advances in machine learning and deep learning have enabled automated image interpretation, enhanced quantitative imaging, accelerated acquisition protocols, single-time-point dosimetry, and supported radiomics and multi-omics analyses. Emerging concepts, such as theranostic digital twins, physics- and biology-informed neural networks, and explainable AI are also discussed as future directions for precision medicine. Despite substantial progress, challenges related to data quality, interpretability, ethics, privacy, standardization, and clinical validation continue to hinder widespread clinical adoption. Nevertheless, AI-driven technologies are expected to play a central role in advancing personalized radiopharmaceutical therapy and facilitating routine dosimetry-guided treatment in clinical practice.
Overall, AI is becoming an integral component of modern oncology, particularly radiation oncology, and its successful integration into routine clinical practice will require robust validation, transparent governance, equitable implementation, and continued clinician oversight to ensure safe, effective, and patient-cent...
K. Rastogi· The Rise of Artificial Intel...· 0 citations
The future of AI in radiation oncology is unlikely to be the replacement of the radiation oncologist, but rather a human–AI partnership in which automation supports clinical expertise, and the need to define responsibility when AI-generated outputs are used in patient care is defined.
S. Ichou, K. Nouni, A. Lachgar et al.· MedPeer publisher· 0 citations
A clinically oriented overview of the current applications of GAI across the lung cancer care continuum is provided and emerging developments, limitations, and future directions are discussed, including domain-specific models, multimodal systems, guideline-integrated decision support, and prospective validation framewo...
Wen-Zheng Zhang, Zhao-Rui Feng, Yi-Tong Liu et al.· Frontiers in Oncology· 0 citations
This narrative review examines the evolution of artificial intelligence in healthcare, with a focus on the transition from early rule-based systems to modern deep learning architectures and their integration into clinical practice, and the emergence of multimodal foundation models that integrate imaging with textual an...
A. Yildirim, Ö. Özdemi̇r· Artificial Intelligence in M...· 0 citations
Artificial intelligence (AI) and radiomics have emerged as promising approaches in lung-cancer imaging by extracting quantitative features from routine medical images beyond visual assessment alone. Proof-of-concept studies span pulmonary nodule characterisation, molecular biomarker prediction, treatment-response asses...
J. Naidu, V. Baskaradoss· Academia Medical Imaging and...· 0 citations
Enforcing physics-based constraints prevents AI models from generating unreliable predictions for complex nonlinear systems in weather, climate, and turbulent flows.
MIT News · Artificial Intelligence· news.mit.eduNov 20, 2026
An MIT and Dana-Farber Institute-led team used large language models to examine nearly 4,000 studies and hundreds of code repositories, revealing gaps in the information needed to scrutinize and reuse published research.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.